Dr. James Calder Major, MD

Dr. Major practices at Retina Consultants of Houston in Bellaire, Texas.

Dr. Major's NPI, 1700076783, was assigned on July 26, 2007. Dr. Major graduated from Baylor College Of Medicine in 2003. Dr. Major holds Texas license N2637.

Dr. Major's primary practice is Retina Consultants of Houston, at 6300 W S Loop, Bellaire, TX 77401 in Harris County. The practice phone is (713) 524-3434.

Dr. Major's primary practice is Retina Consultants of Houston in Bellaire, Texas. Dr. Major is also affiliated with Houston Methodist Hospital. Dmand AI also links Dr. Major to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Major practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Major's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Major is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Major's licenses on file in 3 states: Texas, Florida and Virginia.

Dmand AI lists age-related macular degeneration, cataract, cold sores or genital herpes, dry eye, glaucoma, hypertensive retinopathy, inflammation of iris and retinal detachment among the conditions Dr. Major treats.

CMS data shows 19,074 Medicare services from Dr. Major across 17 procedure codes in 2024, for 977 Medicare patients. Medicare paid $3,106,899 for them. Every service was in an office.

CMS counts 977 Medicare patients who saw Dr. Major in 2024. The largest group is 65 to 74, with 436 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Major's median patient age at 71, with 58% women.

In 2024, Dr. Major wrote 318 Medicare Part D claims for 115 patients. 63% of them were for generic drugs. CMS names the drug for 258 of them, across 11 drugs with 11 or more claims each, at $18,914 in total drug cost. In 2023, CMS named 306 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Major for performance year 2024, reported as part of a group. Dr. Major accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 29 papers to Dr. Major, published from 2009 to 2025. 2010 was the busiest year, with 4. The most frequent topics are Angiogenesis Inhibitors, Tomography, Optical Coherence and Visual Acuity. Dr. Major has published most often in Retina. Dr. Major's most frequent co-authors are Charles Clifton Wykoff, MD, PhD, Tien P. Wong, MD and David M. Brown, MD.

Dmand AI links Dr. Major to 6 clinical trials, 4 of them phase 2 studies. Conditions studied include Diabetic Retinopathy, Macular Edema and Vitreous Hemorrhage. Greater Houston Retina Research sponsors the most, 3.

CMS Open Payments shows 247 general payments to Dr. Major from 18 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 65% of the total. Genentech, Inc. paid the most, $69,041.

Dmand AI lists 2 awards for Dr. Major.

Dr. Major graduated from Baylor College Of Medicine in 2003. Dr. Major is a member of AAO and ACS.

Dr. Major is in network with 24 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.